The burgeoning landscape of emerging treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://idadkuz512066.wikiparticularization.com/1991013/retatrutide_vs_tirzepatide_a_comparative_analysis